Related Experiment Video
Updated: Feb 7, 2026
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Clinical Approach to Community-acquired Pneumonia
Catia Cillóniz1, Diana Rodríguez-Hurtado2, Antonello Nicolini3
1Department of Pneumology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Ciberes, Barcelona, Spain.
Community-acquired pneumonia (CAP) is a significant global health issue, particularly in older adults. Prevention through vaccination and prudent antibiotic use are key to managing this serious lung infection and combating rising antibiotic resistance.
Area of Science:
- Infectious Diseases
- Pulmonology
- Public Health
Background:
- Community-acquired pneumonia (CAP) represents a substantial global health burden.
- Incidence and healthcare costs associated with CAP increase with age and risk factors.
- High mortality rates persist in CAP patients requiring intensive care unit (ICU) admission.
Purpose of the Study:
- To provide a comprehensive review of community-acquired pneumonia (CAP).
- To focus on key aspects including epidemiology, diagnosis, and treatment.
- To highlight prevention strategies and the challenge of antibiotic resistance.
Main Methods:
- Literature review of community-acquired pneumonia (CAP).
- Analysis of epidemiological data and risk factors.
- Examination of current therapeutic guidelines and preventative measures.
Main Results:
- Pneumococcus is identified as the most frequent pathogen in CAP.
- Antibiotic resistance, particularly in pneumococcus, is a critical global concern.
- Vaccination against pneumococcus and influenza is the primary prevention strategy.
Conclusions:
- Prudent antibiotic stewardship is essential to limit the spread of resistant pneumococcal strains.
- Vaccination remains the cornerstone of CAP prevention, especially for at-risk populations.
- Effective management of CAP requires a multifaceted approach addressing diagnosis, therapy, and prevention.
More Related Videos
04:29Author Spotlight: Developing Synthetic Microbial Communities for Generating Second-Generation Biofertilizers
Published on: May 24, 2024
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
00:30What are Populations and Communities?
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....